menopausal symptoms. Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
Conditions
Interventions
Intervention 1: First group will be given Tab agnugol oral, 2 times daily for 8 weeks. Intervention 2: Second group will be Placebo Tab oral, 2 times daily for 8 weeks.
Treatment - Drugs
First group will be given Tab agnugol oral, 2 times daily for 8 weeks.
Second group will be Placebo Tab oral, 2 times daily for 8 weeks.
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 65-45 years; at least one year and a maximum of three years of their last menstrual period has passed; the number of hot flashes at least 2 times a day. Exclusion criteria: smoking; at least for a period of 3 months are treated with hormones and antibiotics; systemic diseases such as kidney disease; blood pressure blood sugar; blood fat; depressed and anxious (anxiety and depression diagnosis based on diagnostic criteria DSM5 by psychiatrist); taking antithyroid drugs; gabapentin; SSRI; sulfonamides, methotrexate, Tryamtryn, sulfasalazine; the use of traditional medicines such as drug-induced flushing.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menopausal symptoms. Timepoint: before intervention- 2 weeks later- 4 weeks later- 8 weeks later. Method of measurement: Green Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed